A family office can model liquidity risk, concentration risk, tax exposure, succession risk, counterparty risk, and key-person risk with extraordinary precision.
But there is a category of risk that almost never appears on the dashboard: how much biological reserve the decision-maker has left when demand suddenly rises.
That is different from asking whether someone is “healthy.” It is different from asking whether their blood work is normal. And it is very different from asking for a biological-age score.
The question I think matters more is this:
How much margin exists between what your life demands from you and what your body and brain can reliably deliver?
I call that the Reserve Margin.
It may be one of the most useful ways to think about executive healthspan.
Health is not a binary state
Most people still think about health in a binary way: sick or well, diagnosed or not diagnosed, cleared or not cleared.
That model works reasonably well for acute medicine. It works poorly for long-horizon performance.
Two people can both be free of a major diagnosis and still have radically different capacity.
One can tolerate three days of travel, a difficult board meeting, a poor night of sleep, a respiratory infection, and a stressful negotiation — and still function at a high level.
The other can look fine on paper but operate close to the edge. One bad week exposes the fragility.
That difference is reserve.
The World Health Organization’s healthy-aging framework emphasizes functional ability — the capacity to be and do what matters — rather than simply the absence of disease. That is much closer to the way I think about longevity for leaders.
A high-performing founder does not merely need to avoid catastrophe. He or she needs enough cognitive, physiologic, structural, and recovery capacity to continue making good decisions when conditions are imperfect.
That is why the key metric is not age.
It is margin.
The equation I care about
Here is the simplest version of the concept:
Reserve Margin = Capacity − Demand
Capacity is what your system can reliably produce.
Demand is what your life repeatedly requires.
When the margin is wide, you are resilient.
When the margin is narrow, small disruptions become large problems.
This is not a validated clinical equation. It is a decision framework. But it explains something that many executives intuitively understand from business and rarely apply to themselves.
A company with no cash buffer may look profitable until volatility arrives.
A person with no biological buffer may look healthy until stress exposes the deficit.
Demand is not the enemy
The obvious conclusion would be to reduce stress, travel less, sleep perfectly, and make life easier.
That is not realistic for many people who are building companies, leading families, or managing complex institutions.
The better strategy is to understand both sides of the equation.
Sometimes demand can be reduced.
Sometimes capacity can be expanded.
Often the biggest opportunity is to improve recovery so the system resets faster between periods of demand.
That creates three levers:
1. Lower unnecessary demand.
Reduce avoidable sleep disruption, poorly designed travel, chronic pain, unmanaged disease, needless decision overload, and self-created friction.
2. Expand capacity.
Improve cardiorespiratory fitness, muscular reserve, mobility, metabolic control, cardiovascular risk management, sensory function, and sleep quality.
3. Improve recovery speed.
Build enough physiologic and structural resilience that illness, surgery, stress, travel, or a bad week does not produce a prolonged collapse in function.
That is a very different philosophy from chasing optimization for its own sake.
Why this matters for cognition
Executives often treat cognitive performance as if it were independent of the body.
It is not.
A 2024 meta-analysis of 44 studies found that even a single night of restricted sleep increased sleepiness and impaired sustained attention. That does not mean one short night makes someone incapable of leadership. It means attention is biological, and the margin can move quickly.
More recent work is reinforcing the same systems-level idea. A 2026 UK Biobank analysis of more than 30,000 participants found meaningful covariance between body physiology, brain measures, and cognition. A separate 2026 study in cognitively normal older adults found distinct associations between aerobic and muscular fitness and measures of brain health.
These are observational relationships, not proof that improving one variable automatically improves executive decision-making. But the pattern matters: the brain is not floating above the body. It is embedded in it.
That should change how leaders think about performance.
The family-office mistake: focusing only on catastrophic risk
Traditional risk management asks, “What happens if the founder dies or becomes disabled?”
That is important.
But there is a much larger zone between full capacity and catastrophe.
What happens if attention declines 15%?
What happens if chronic pain changes behavior?
What happens if sleep quality deteriorates for three years?
What happens if fitness falls enough that travel becomes exhausting?
What happens if hearing loss, vision changes, metabolic disease, or medication burden gradually alters decision quality?
None of these events looks dramatic on its own.
But leadership is a compounding activity. Small degradations can matter when they affect hundreds of decisions over years.
That is why I believe family-enterprise health strategy should be built around preserving reserve, not simply preventing disaster.
A private Reserve Review
I am not proposing that a family office become a medical institution. Health information is private. Participation should be voluntary. Clinical decisions belong between the individual and qualified clinicians.
But the individual leader can still use a disciplined framework.
Once or twice a year, I would ask four questions:
Where is my narrowest reserve?
Is the limiting system cognitive, cardiovascular, metabolic, structural, sensory, sleep-related, or recovery-related?
What demand repeatedly consumes that reserve?
Travel? Pain? Poor sleep? Long sedentary periods? Chronic stress? Untreated risk factors? A schedule that never permits recovery?
Which intervention would actually widen the margin?
Not which intervention is fashionable. Which one changes capacity or demand in a meaningful way?
How will I know whether it worked?
Not “Did my dashboard improve?” but “Did function, resilience, or risk actually improve?”
That is Decision-Grade Longevity in practical form.
What should be measured?
Not everything.
That is one of the biggest mistakes in modern longevity medicine.
More data are not automatically more insight.
The strongest current evidence still supports many unglamorous variables: blood pressure, cardiovascular risk, cardiorespiratory fitness, body composition, muscle strength, physical function, sleep, bone health, sensory function, and established disease screening where appropriate.
Cardiorespiratory fitness is particularly interesting because a 2024 overview of meta-analyses representing more than 20.9 million observations found a strong and consistent association between higher fitness and lower morbidity and mortality. That is not proof that one fitness number causes a specific outcome in an individual. It is a powerful signal that reserve matters.
Advanced testing may add value in selected situations. But it should earn its place by changing a decision.
The goal is not to become invulnerable
No one has infinite reserve.
A highly fit person can still become ill. A disciplined executive can still develop disease. A great longevity program cannot eliminate uncertainty.
The goal is not invulnerability.
It is optionality.
A wider reserve margin gives you more room to absorb the unexpected without sacrificing function.
That is exactly why companies maintain liquidity.
It is why aviation systems build redundancy.
It is why surgeons care about physiologic reserve before major procedures.
And it is why leaders should think about healthspan as infrastructure rather than as a side project.
The larger idea
Wealth creates options.
Biological reserve determines how many of those options you remain capable of using.
The real objective of executive longevity is not to win a contest for the youngest biomarker profile.
It is to preserve enough margin to think clearly, move freely, recover quickly, and remain useful to the people and institutions that depend on you.
The balance sheet is missing a column.
I think it is time we added one.